The Oncology Institute (TOI)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
CEO:
Bradford D. Hively
Employees:
660
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
562-735-3226

The Oncology Institute provides medical oncology services in the United States. Services include physician services, in-house infusion and dispensary, clinical trial services, stem cell transplants and transfusions programs. The company was founded in 2007 and is based in Cerritos, California.

Data derived from most recent annual or quarterly report
Market Cap 30.566 Million Shares Outstanding74.552 Million Avg 30-day Volume 386.992 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.55
Price to Revenue0.1814 Debt to Equity1.0134 EBITDA-31.627 Million
Price to Book Value0.506 Operating Margin0.0 Enterprise Value134.27 Million
Current Ratio EPS Growth-11.714 Quick Ratio
1 Yr BETA 0.7803 52-week High/Low 7.6 / 0.33 Profit Margin-17.8962
Operating Cash Flow Growth-20.1536 Altman Z-Score Free Cash Flow to Firm -76.107 Million

Are you looking for this stock instead?

View SEC Filings from TOI instead.

View recent insider trading info

The Oncology Institute YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TOI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TOI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-24 by SHAH MIHIR
  • 4: filed on 2023-03-21 by MILLER MATTHEW P
  • 4: filed on 2023-03-21 by SARIN RAVI YANG
  • 4: filed on 2023-03-21 by VIRNICH DANIEL
  • 4: filed on 2023-03-21 by O'MEARA MAEVE
  • 4: filed on 2023-03-21 by MCGEORGE ANNE
  • 4: filed on 2023-03-21 by PACALA MARK L
  • 4: filed on 2023-03-21 by JOHNSON KAREN MARIE
  • 4: filed on 2023-03-21 by HIVELY BRAD
  • 4/A: filed on 2022-12-30 by BARASCH RICHARD A

    • Events (8k)

  • 8-K: filed on 2023-05-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-27:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-03-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-03-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SHAH MIHIR CHIEF FINANCIAL OFFICER

    • Officer
    		 223,472 2023-05-23 3

    BARASCH RICHARD A

    • Director
    		 257,201 2023-03-17 4

    PACALA MARK L

    • Director
    		 88,399 2023-03-17 2

    SARIN RAVI YANG

    • Director
    		 4,185,198 2023-03-17 2

    KAUSHAL MOHIT

    • Director
    		 42,393 2023-03-17 3

    O'MEARA MAEVE

    • Director
    		 59,104 2023-03-17 2

    MCGEORGE ANNE

    • Director
    		 71,346 2023-03-17 2

    PODNOS YALE CHIEF MEDICAL OFFICER

    • Officer
    		 90,466 2023-03-17 4

    VIRNICH DANIEL PRESIDENT

    • Officer
    		 738,529 2023-03-17 5

    HIVELY BRAD CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 724,182 2023-03-17 4

    JOHNSON KAREN MARIE

    • Director
    		 63,185 2023-03-17 2

    MILLER MATTHEW P CHIEF OPERATING OFFICER

    • Officer
    		 242,992 2023-03-17 5

    SIMONEIT DIONA CHIEF ACCOUNTING OFFICER

    • Officer
    		 92,427 2022-11-17 3

    LING GABRIEL

    • Director
    		 29,057 2022-11-17 1

    HAVENCREST HEALTHCARE PARTNERS, L.P.

    HAVENCREST HEALTHCARE PARTNERS GP, LLC

    TOI HC I, LLC

    • 10% Owner
    		 13,362,873 2022-11-11 5

    AGAJANIAN RICHY

    JIMMY HOLDINGS, INC.

    • 10% Owner
    		 6,549,124 2022-06-10 1

    DALGLEISH SCOTT CHIEF FINANCIAL OFFICER

    • Officer
    		 162,891 2022-03-21 0

    DFP SPONSOR LLC

    HOCHBERG STEVEN

    ATINSKY LAWRENCE

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    		 3,177,583 2021-11-12 0

    SARIN RAVI YANG

    ONCOLOGYCARE PARTNERS, LLC

    • Director
    		 4,109,771 2021-11-12 2

    M33 GROWTH I L.P.

    M33 GROWTH I GP LLC

    TOI M, LLC

    • 10% Owner
    		 15,256,383 2021-11-12 0

    FLYNN JAMES E

    DEERFIELD MGMT IV, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    		 5,000,000 2020-03-13 0

    WOLFE CHRIS CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-03-10 0

    DFP SPONSOR LLC DIRECTOR BY DEPUTIZATION

    ATINSKY LAWRENCE DIRECTOR BY DEPUTIZATION

    • Director
    • 10% Owner
    		 0 2020-03-10 0

    SORENSEN GREGORY

    • Director
    		 0 2020-03-10 0

    CARTER JENNIFER L.

    • Director
    		 0 2020-03-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SHAH MIHIR - Officer CHIEF FINANCIAL OFFICER

    		2023-05-24 20:43:26 -0400 2023-05-23 D 869 $0.43 d 223,472 direct -3.6957 -5.4348 0.0 1 -11.7391 5

    SHAH MIHIR - Officer CHIEF FINANCIAL OFFICER

    		2023-05-24 20:43:26 -0400 2023-05-23 D 2,573 $0.43 d 224,341 direct -3.6957 -5.4348 0.0 1 -11.7391 5

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 22:15:03 UTC -8.1281 13.1981 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 21:45:05 UTC -8.1281 13.1981 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 21:15:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 20:45:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 20:15:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 19:45:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 19:15:03 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 18:45:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 18:15:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 17:45:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 17:15:04 UTC -8.3271 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 16:45:04 UTC -8.3371 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 16:15:03 UTC -8.3371 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 15:45:04 UTC -8.3371 13.3971 20000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 15:15:04 UTC -8.3371 13.3971 25000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 14:45:04 UTC -5.7839 10.8439 25000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 14:15:03 UTC -5.7839 10.8439 25000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 13:45:03 UTC -5.7839 10.8439 25000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 13:15:03 UTC -5.7839 10.8439 25000
    ONCOLOGY INSTITUTE INC-THE TOI 2023-06-06 12:45:05 UTC -5.7839 10.8439 25000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments